161 related articles for article (PubMed ID: 23822987)
1. Diagnostic and therapeutic use of MIBG in pheochromocytoma and paraganglioma.
Aktolun C; Castellani MR; Bombardieri E
Q J Nucl Med Mol Imaging; 2013 Jun; 57(2):109-11. PubMed ID: 23822987
[No Abstract] [Full Text] [Related]
2. [131I-meta-iodobenzylguanidine (MIBG) for the detection and therapy of pheochromocytoma and neuroblastoma].
Nakajo M; Shinohara S
Rinsho Hoshasen; 1987 Apr; 32(4):461-70. PubMed ID: 3613180
[No Abstract] [Full Text] [Related]
3. Iodine-131 metaiodobenzylguanidine (I-131 MIBG) diagnosis and therapy of pheochromocytoma and paraganglioma: current problems, critical issues and presentation of a sample case.
Castellani MR; Aktolun C; Buzzoni R; Seregni E; Chiesa C; Maccauro M; Aliberti GL; Vellani C; Lorenzoni A; Bombardieri E
Q J Nucl Med Mol Imaging; 2013 Jun; 57(2):146-52. PubMed ID: 23822990
[TBL] [Abstract][Full Text] [Related]
4. Applications of [131I]m-iodobenzylguanidine ([131I]MIBG).
Beierwaltes WH
Int J Rad Appl Instrum B; 1987; 14(3):183-9. PubMed ID: 3312118
[TBL] [Abstract][Full Text] [Related]
5. [Iodine-131 meta-iodobenzylguanidine for the diagnosis and treatment of pheochromocytoma and tumors of neural crest origin].
Horne T
Harefuah; 1992 Apr; 122(8):526-9. PubMed ID: 1398325
[No Abstract] [Full Text] [Related]
6. Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.
Modak S; Zanzonico P; Carrasquillo JA; Kushner BH; Kramer K; Cheung NK; Larson SM; Pandit-Taskar N
J Nucl Med; 2016 Feb; 57(2):231-7. PubMed ID: 26742708
[TBL] [Abstract][Full Text] [Related]
7. Effects and safety of ¹³¹I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: results from a multicenter observational registry.
Yoshinaga K; Oriuchi N; Wakabayashi H; Tomiyama Y; Jinguji M; Higuchi T; Kayano D; Fukuoka M; Inaki A; Toratani A; Okamoto S; Shiga T; Ito YM; Nakajo M; Nakajo M; Kinuya S; ; ;
Endocr J; 2014; 61(12):1171-80. PubMed ID: 25214026
[TBL] [Abstract][Full Text] [Related]
8. [(131)I] and [(125)I] metaiodobenzylguanidine therapy in macroscopic and microscopic tumors: a comparative study in SK-N-SH human neuroblastoma and PC12 rat pheochromocytoma xenografts.
Rutgers M; Buitenhuis CK; van der Valk MA; Hoefnagel CA; Voûte PA; Smets LA
Int J Cancer; 2000 Dec; 90(6):312-25. PubMed ID: 11180134
[TBL] [Abstract][Full Text] [Related]
9. The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors.
Shapiro B; Sisson JC; Shulkin BL; Gross MD; Zempel S
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):55-7. PubMed ID: 9002750
[TBL] [Abstract][Full Text] [Related]
10.
Sugiyama M; Seigo K; Hosoya Y; Iguchi A; Manabe A
Pediatr Int; 2020 Jun; 62(6):746-747. PubMed ID: 32478419
[No Abstract] [Full Text] [Related]
11. Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/paraganglioma and neuroblastoma.
Fukuoka M; Taki J; Mochizuki T; Kinuya S
Clin Nucl Med; 2011 Jan; 36(1):1-7. PubMed ID: 21157198
[TBL] [Abstract][Full Text] [Related]
12. Current concepts on the diagnostic use of MIBG in children.
Shulkin BL; Shapiro B
J Nucl Med; 1998 Apr; 39(4):679-88. PubMed ID: 9544682
[TBL] [Abstract][Full Text] [Related]
13. MIBG (metaiodobenzylguanidine) theranostics in pediatric and adult malignancies.
Agrawal A; Rangarajan V; Shah S; Puranik A; Purandare N
Br J Radiol; 2018 Nov; 91(1091):20180103. PubMed ID: 30048149
[TBL] [Abstract][Full Text] [Related]
14. High-Specific-Activity-
Jha A; Taïeb D; Carrasquillo JA; Pryma DA; Patel M; Millo C; de Herder WW; Del Rivero J; Crona J; Shulkin BL; Virgolini I; Chen AP; Mittal BR; Basu S; Dillon JS; Hope TA; Mari Aparici C; Iagaru AH; Hicks RJ; Avram AM; Strosberg JR; Civelek AC; Lin FI; Pandit-Taskar N; Pacak K
Clin Cancer Res; 2021 Jun; 27(11):2989-2995. PubMed ID: 33685867
[TBL] [Abstract][Full Text] [Related]
15. A phase I clinical trial for [
Inaki A; Yoshimura K; Murayama T; Imai Y; Kuribayashi Y; Higuchi T; Jinguji M; Shiga T; Kinuya S
J Med Invest; 2017; 64(3.4):205-209. PubMed ID: 28954983
[TBL] [Abstract][Full Text] [Related]
16. [Neuroblastoma in Recklinghausen's disease].
Bruchhausen A; Eissner D; Hahn K
Rofo; 1988 Sep; 149(3):332-3. PubMed ID: 2843971
[No Abstract] [Full Text] [Related]
17. Radioiodinated iodobenzylguanidines for diagnosis and therapy.
McEwan AJ; Wyeth P; Ackery D
Int J Rad Appl Instrum A; 1986; 37(8):765-75. PubMed ID: 3021678
[TBL] [Abstract][Full Text] [Related]
18. [Nuclear medicine diagnosis and treatment in pheochromocytoma and neuroblastoma].
Fischer M
Bildgebung; 1987-1989; 56(4):141-5. PubMed ID: 3271589
[TBL] [Abstract][Full Text] [Related]
19. Iodine-131 MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma.
Shulkin BL; Shen SW; Sisson JC; Shapiro B
J Nucl Med; 1987 Mar; 28(3):315-8. PubMed ID: 3102702
[TBL] [Abstract][Full Text] [Related]
20. 123I-meta-iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis.
Jacobson AF; Deng H; Lombard J; Lessig HJ; Black RR
J Clin Endocrinol Metab; 2010 Jun; 95(6):2596-606. PubMed ID: 20392867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
